Ple162-EGFP/cre (Positive)*
|
|
Other constructs for this MiniPromoter: Ple162-EGFP (Negative) |
Other constructs for this Gene: Ple160-EGFP/cre (Negative), Ple161-EGFP/cre (Negative),
Ple160-lacZ (Positive), Ple160-EGFP (Negative), Ple161-EGFP (Negative) |
|
|
|
|
|
|
Ple162-EGFP/cre Description:
This Ple162 promoter construct is derived from the promoter region of the Pituitary
homeobox 3 (PITX3) gene. The Pleiades Promoter Project created a 3636 bp MiniPromoter
derived from an intronic candidate regulatory region and a segment of the PITX3
promoter and introduced it into the multiple cloning site (MCS) of Pleiades expression
vector pEMS1302 (EGFP/cre reporter flanked by minimal frt sites) to make plasmid
pEMS1148 with Ple162 driving EGFP/cre. The Ple162-EGFP/cre (pEMS1148) was introduced
by homologous recombination as a single copy insertion into the Hprt1b-m3 locus
in the X chromosome of mouse embryonic stem cells (ESCs) mEMS21. The ESC lines mESM942,
mEMS951, and mESM954 were PCR validated and chimeras were generated using mEMS954
Note: Promoterless negative controls (pEMS1302, pEMS1306, pEMS1313)
have been generated, as well as CAG positive controls (pEMS1157,
pEMS1277 & pEMS1488).
|
|
|
Ple162-EGFP/cre Expression Pattern:
Expression of the Ple162-EGFP/cre results in the rearrangement of the Gt(ROSA)26tm1Sor reporter locus, thus producing strong ßGal activity in a discrete neuronal-like cell population in the ventral midbrain. In the mature brain, ßGal-positive cells are found surrounding the fasciculus retroflexus. Double labeling for ßGal and tyrosine hydroxylase shows that the ßGal-positive cells are not dopaminergic cells, but do border the dorsal edge of the main dopaminergic population of the VTA. A developmental analysis showed clear ßGal labeling of ventral midbrain cells in embryonic day 11.5 (E11.5) and E15.5 embryos as well as postnatal day 0 (P) and P7 pups, in the regions from and through which the dopaminergic population arises and migrates, respectively. Active expression of the EGFP/cre reporter gene product, however, cannot be detected in these cells by EGFP immunostaining, indicating ßGal expression is an historical marker of expression of the EGFP/cre reporter. Additionally, a substantial non-CNS staining was detected in muscle tissue of the abdominal wall, limb buds and posterior paravertebral tissues in E11.5 whole embryos as expected for the PITX3 gene.
|
|
|
Ple162 MiniPromoter Resources:
|
|
|
Publications:| Reference | PubMed ID |
|---|
| Semina EV, Murray JC, Reiter R, Hrstka RF, Graw J. Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum Mol Genet. 2000 Jul 1;9(11):1575-85. | 10861284 | | Smidt MP, Smits SM, Bouwmeester H, Hamers FP, van der Linden AJ, Hellemons AJ, Graw J, Burbach JP. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development. 2004 Mar;131(5):1145-55. | 14973278 | | Smidt MP, van Schaick HS, Lanctot C, Tremblay JJ, Cox JJ, van der Kleij AA, Wolterink G, Drouin J, Burbach JP. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13305-10. | 9371841 | | Rieger DK, Reichenberger E, McLean W, Sidow A, Olsen BR. A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice. Genomics. 2001 Feb 15;72(1):61-72. | 11247667 | | Maxwell SL, Ho HY, Kuehner E, Zhao S, Li M. Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev Biol. 2005 Jun 15;282(2):467-79. | 15950611 | | Coulon V, L'Honore A, Ouimette JF, Dumontier E, van den Munckhof P, Drouin J. A muscle-specific promoter directs Pitx3 gene expression in skeletal muscle cells. J Biol Chem. 2007 Nov 9;282(45):33192-200. Epub 2007 Sep 11. | 17848564 | | Zhao S, Maxwell S, Jimenez-Beristain A, Vives J, Kuehner E, Zhao J, O'Brien C, de Felipe C, Semina E, Li M. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur J Neurosci. 2004 Mar;19(5):1133-40. | 15016072 | | Castillo-Carranza DL, Rodriguez-Rocha H, Montes-de-Oca-Luna R, Sepulveda-Saavedra J, Martinez HR, Lopez-Vidal Y, Saucedo-Cardenas O. Pitx3 promoter directs Cre-recombinase specifically in a human neuroblastoma cell line. Mol Cell Biochem. 2008 Feb;309(1-2):223-7. Epub 2007 Nov 30. | 18049867 | | Hedlund EM, Pruszak J, Lardaro T, Ludwig W, Vinuela A, Kim KS, Isacson O. Embryonic Stem (ES) Cell-derived Pitx3-eGFP Midbrain Dopamine Neurons Survive Enrichment by FACS and Function in an Animal Model of Parkinson's Disease. Stem Cells. 2008 Apr 3; [Epub ahead of print] | 18388307 | | 0 | | Qiu HY, Guo C, Cheng XW, Huang Y, Xiong ZQ, Ding YQ. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles. Genesis. 2008 Jun;46(6):324-8. | 18543300 | | Doni A, Mantovani G, Porta C, Tuckermann J, Reichardt HM, Kleiman A, Sironi M, Rubino L, Pasqualini F, Nebuloni M, Signorini S, Peri G, Sica A, Beck-Peccoz P, Bottazzi B, Mantovani A. Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells. J Biol Chem. 2008 Aug 14; [Epub ahead of print] | 18703503 | | Jacobs FM, Van der Linden AJ, Wang Y, von Oerthel L, Sul HS, Burbach JP, Smidt MP. Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development. 2009 Jun 10; [Epub ahead of print] | 19515692 |
|
|
|
|
* The Ple162 MiniPromoter (Patent Pending) is proprietary - any commercial
use of the MiniPromoter will require a direct license from The University of British
Columbia. Please direct all licensing inquiries to Sue Kingsley, MBA, PhD,
sue@biopharmasolutions.com Office:
604-408-4310
|
|